Rising Industrial Concentration in Hollow Capsule Production: Small Factories Accelerate Elimination

Dec 23, 2025

Leave a message

Key Drivers for the Elimination of Small-Scale Factories

The accelerated elimination of small hollow capsule factories is not an accidental phenomenon but the result of multiple overlapping factors, including tightened regulatory requirements, environmental constraints, and inherent operational disadvantages. These factors have collectively raised the industry's entry threshold, making it increasingly difficult for small factories to survive.

1. Stringent Implementation of GMP Standards and Regulatory Supervision

As a critical upstream component of the pharmaceutical industry, hollow capsules are subject to strict quality supervision. In recent years, the National Medical Products Administration (NMPA) has continuously strengthened the implementation of Good Manufacturing Practices (GMP) for pharmaceutical excipients, imposing rigorous requirements on the production environment, quality control systems, raw material sourcing, and finished product testing of hollow capsule factories. For small factories, meeting these standards requires substantial investment in upgrading production facilities (such as clean workshops, automated production lines, and precision testing equipment), establishing a complete quality management system, and training professional quality control personnel. Many small factories, constrained by limited capital and technical capabilities, are unable to complete the necessary upgrades within the regulatory timeframe, leading to forced shutdowns or withdrawals from the market.

In addition, NMPA has intensified random inspections and spot checks on hollow capsule products, focusing on key quality indicators such as heavy metal residues (lead, cadmium), microbial contamination, and dissolution rates. Small factories, which often have inadequate quality control capabilities and unstable production processes, are more likely to fail these inspections, resulting in product recalls, fines, or even revocation of production licenses. This has further accelerated their exit from the market.

2. Escalating Environmental Protection Pressure

Hollow capsule production involves processes such as raw material dissolution, drying, and cleaning, which generate certain amounts of wastewater, waste gas, and solid waste. With the continuous tightening of national environmental protection policies (such as the "Double Carbon" goal and strict emission standards), environmental protection has become a crucial survival threshold for hollow capsule enterprises. To comply with environmental regulations, factories need to invest in environmental protection facilities such as wastewater treatment systems, waste gas purification equipment, and solid waste disposal devices, and bear the ongoing operating costs of these facilities.

Small hollow capsule factories, which typically have low profit margins and limited financial capacity, often struggle to afford the high costs of environmental protection upgrades. Some small factories even engage in illegal activities such as unregulated discharge to reduce costs, which have been severely cracked down on by environmental protection authorities. Under the dual pressure of policy constraints and cost burdens, a large number of small factories that fail to meet environmental standards have been shut down.

3. Lack of Scale Effect and Competitive Disadvantages

Hollow capsule production has significant economies of scale. Large-scale enterprises can reduce unit production costs through bulk purchasing of raw materials (such as gelatin, HPMC, and glycerin), efficient utilization of production equipment, and centralized management of labor resources. In contrast, small factories have small production volumes, resulting in higher raw material procurement costs (due to the lack of bargaining power with suppliers), lower equipment utilization rates, and higher per-unit labor costs. This makes their products less price-competitive in the market.

Furthermore, downstream pharmaceutical enterprises (the main customers of hollow capsules) are increasingly inclined to cooperate with large, reputable hollow capsule manufacturers to ensure the stability and safety of their supply chains. Pharmaceutical companies, especially large domestic and international pharmaceutical groups, have strict supplier qualification certification systems, requiring hollow capsule suppliers to have stable production capacity, complete quality assurance systems, and strong R&D capabilities. Small factories, which often have unstable product quality, limited production capacity, and weak R&D capabilities, are unable to pass these qualification certifications, losing access to key customers and market opportunities. This further exacerbates their competitive disadvantage and accelerates their elimination.